Ramesh Jois

Deciphering O -glycoprotease substrate preferences with O-Pair Search

Introduction to quality engineering....

Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis

Reading the glyco-code: New approaches to studying protein–carbohydrate interactions

Role of Regulatory T Cells (Treg) and the Treg Effector Molecule Fibrinogen-like Protein 2 in Alloimmunity and Autoimmunity

Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis

Measuring the multifaceted roles of mucin-domain glycoproteins in cancer

Revealing the human mucinome

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis

A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics

Glycoproteomics

Psoriasis Pathogenesis and Treatment

Uniform Design: Theory and Application

Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics

Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis

Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy

Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients

Low-dose infliximab treatment for ankylosing spondylitis--clinically- and cost-effective

Rituximab therapy in patients with resistant rheumatoid arthritis: real-life experience

Rheumatoid arthritis management in the APLAR region: Perspectives from an expert panel of rheumatologists, patients and community oriented program for control of rheumatic diseases